Adherence to 5-Alpha Reductase Inhibitor Therapy For Benign Prostatic Hyperplasia: Clinical and Economic Outcomes

Stephen K. Gruschkus,Sara A. Poston,Michael Eaddy,Sham Chaudhari

Adherence to 5-Alpha Reductase Inhibitor Therapy For Benign Prostatic Hyperplasia: Clinical and Economic Outcomes

2012

Stephen K. Gruschkus
Sara A. Poston
Michael Eaddy
Sham Chaudhari

Objective: Our goal was to quantify relationships between adherence to 5-alpha reductase inhibitors (5-ARIs), the risk of acute urinary retention (AUR) and prostate surgery, and medical costs related to patients with benign prostatic hyperplasia (BPH).

Keywords:

Urology
Prostate surgery
5 Alpha-Reductase Inhibitor
Reductase
Gynecology
Urinary retention
Hyperplasia
Medicine
Multivariate analysis
Pharmacoeconomics
Hazard ratio
Persistence (computer science)

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations